Cargando…
Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
Alzheimer’s disease (AD) is a major public health priority with a large socioeconomic burden and complex etiology. The Alzheimer Disease Metabolomics Consortium (ADMC) and the Alzheimer Disease Neuroimaging Initiative (ADNI) aim to gain new biological insights in the disease etiology. We report here...
Autores principales: | Barupal, Dinesh Kumar, Fan, Sili, Wancewicz, Benjamin, Cajka, Tomas, Sa, Michael, Showalter, Megan R., Baillie, Rebecca, Tenenbaum, Jessica D., Louie, Gregory, Kaddurah-Daouk, Rima, Fiehn, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244184/ https://www.ncbi.nlm.nih.gov/pubmed/30457571 http://dx.doi.org/10.1038/sdata.2018.263 |
Ejemplares similares
-
Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019) -
A Comprehensive Plasma Metabolomics Dataset for a Cohort of Mouse Knockouts within the International Mouse Phenotyping Consortium
por: Barupal, Dinesh K., et al.
Publicado: (2019) -
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019) -
Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017) -
A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases
por: Kyle, Jennifer E., et al.
Publicado: (2021)